Share Rambam Health Care Campus Publication Date: November 17, 2021 An engineered protein – Sema 3C – for treating eye disorders and specifically age-related macular degeneration (AMD) and/or reducing abnormal angiogenesis and lymphangiogenesis in a patient’s eye.